TrialClinical cancer research : an official journal of the American Association for Cancer Research2017

A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Myron S Czuczman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.